These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11751750)

  • 1. Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation.
    Campanelli R; Palermo B; Garbelli S; Mantovani S; Lucchi P; Necker A; Lantelme E; Giachino C
    Int Immunol; 2002 Jan; 14(1):39-44. PubMed ID: 11751750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.
    Denkberg G; Cohen CJ; Reiter Y
    J Immunol; 2001 Jul; 167(1):270-6. PubMed ID: 11418659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK; Donnenberg VS; Friebe-Hoffmann U; Meyer EM; Rinaldo CR; DeLeo AB; Whiteside TL; Donnenberg AD
    Cytometry; 2000 Dec; 41(4):321-8. PubMed ID: 11084618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers.
    Daniels MA; Jameson SC
    J Exp Med; 2000 Jan; 191(2):335-46. PubMed ID: 10637277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer staining.
    Clement M; Ladell K; Ekeruche-Makinde J; Miles JJ; Edwards ES; Dolton G; Williams T; Schauenburg AJ; Cole DK; Lauder SN; Gallimore AM; Godkin AJ; Burrows SR; Price DA; Sewell AK; Wooldridge L
    J Immunol; 2011 Jul; 187(2):654-63. PubMed ID: 21677135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-coreceptor antibodies profoundly affect staining with peptide-MHC class I and class II tetramers.
    Wooldridge L; Scriba TJ; Milicic A; Laugel B; Gostick E; Price DA; Phillips RE; Sewell AK
    Eur J Immunol; 2006 Jul; 36(7):1847-55. PubMed ID: 16783852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between MHC molecules and co-receptors of the TCR.
    König R
    Curr Opin Immunol; 2002 Feb; 14(1):75-83. PubMed ID: 11790535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous clustering of Thy-1 antigens on CD4+ CD8+ thymocytes lacking TCR engagement by MHC/peptide complexes.
    Sano T; Yamamoto K; Fukui Y; Sasazuki T
    Eur J Immunol; 1999 Feb; 29(2):403-12. PubMed ID: 10064055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-receptor-independent signal transduction in a mismatched CD8+ major histocompatibility complex class II-specific allogeneic cytotoxic T lymphocyte.
    Eshima K; Tachibana M; Suzuki H; Yamazaki S; Shinohara N
    Eur J Immunol; 1997 Jan; 27(1):55-61. PubMed ID: 9021998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
    Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
    Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 and CD8 molecules can physically associate with the same T-cell receptor.
    Gallagher PF; Fazekas de St Groth B; Miller JF
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10044-8. PubMed ID: 2513572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.
    Wacholtz MC; Patel SS; Lipsky PE
    J Immunol; 1989 Jun; 142(12):4201-12. PubMed ID: 2470819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR.
    al-Ramadi BK; Jelonek MT; Boyd LF; Margulies DH; Bothwell AL
    J Immunol; 1995 Jul; 155(2):662-73. PubMed ID: 7541822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.
    Laugel B; van den Berg HA; Gostick E; Cole DK; Wooldridge L; Boulter J; Milicic A; Price DA; Sewell AK
    J Biol Chem; 2007 Aug; 282(33):23799-810. PubMed ID: 17540778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56lck adducts in rafts.
    Doucey MA; Legler DF; Boucheron N; Cerottini JC; Bron C; Luescher IF
    Eur J Immunol; 2001 May; 31(5):1561-70. PubMed ID: 11465114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spatial coordination of CD8 and TCR molecules controls antigen recognition by CD8+ T-cells.
    Pecht I; Gakamsky DM
    FEBS Lett; 2005 Jun; 579(15):3336-41. PubMed ID: 15913613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 kinetically promotes ligand binding to the T-cell antigen receptor.
    Gakamsky DM; Luescher IF; Pramanik A; Kopito RB; Lemonnier F; Vogel H; Rigler R; Pecht I
    Biophys J; 2005 Sep; 89(3):2121-33. PubMed ID: 15980174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.